AHA Updates Treatment Guidelines for Atrial Fibrillation
|
By HospiMedica International staff writers Posted on 04 Feb 2019 |
|
Image: New research shows NOACs are preferred over warfarin as an anticoagulant in AF (Photo courtesy of 123RF).
The American Heart Association (AHA; Dallas, TX, USA), American College of Cardiology (ACC; Washington, DC, USA), and the Heart Rhythm Society (HRS; Washington, DC, USA) now recommend the use of non-vitamin K oral anticoagulants (NOACs) over traditional warfarin to prevent stroke in people with atrial fibrillation (AF).
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
The recommendations are the result of a focused update to the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. The new guideline also suggests that NOACs could even be used in people at a lower risk of stroke than previously thought, with emerging research suggesting the benefit of NOACs in stroke reduction risk outweighs the risk of taking them. The recommendation was simultaneously published on January 29, 2019, in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm.
“Patients with atrial fibrillation are at increased risk of stroke, which can be devastating. A goal of treating AF patients is to make blood less likely to form clots, which reduces the risk of stroke,” said Craig T. January, MD, PhD, co-chair of the updated guideline committee. “NOACs may be safer for patients because there is less risk of bleeding, and they may also be more effective at preventing blood clots than warfarin. AF patients should talk to their healthcare provider about any concerns they have about their prescribed medications and whether or not losing weight would benefit their health.”
Until the introduction of NOACs, warfarin had been one of the only treatment options for long-term anticoagulation of patients with AF, venous thromboembolism (VTE), or other conditions that require chronic anticoagulation. The major benefit of the NOAC anticoagulants is that they do not require strict and frequent laboratory monitoring, dosing adjustments, or dietary restrictions, and incur fewer drug interactions than warfarin. NOACs include dabigatran, rivaroxaban, apixaban, and edoxaban.
Related Links:
American Heart Association
American College of Cardiology
Heart Rhythm Society
Gold Member
12-Channel ECG
CM1200B
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Immobilization System
Cranial 4Pi Immobilization
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Latest Critical Care News
- Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use
- Sensor-Integrated Airway Stent Enables Continuous Remote Monitoring
- Graphene-Based Material Selectively Eliminates Bacteria While Sparing Human Cells
- Flexible Plastic Film Uses Nanostructures to Destroy Viruses
- Finger Cuff Algorithm Enables Noninvasive Screening for Aortic Stenosis
- Vibration-Based Tools Aim to Improve Newborn Screening for Heart Defects
- Dried Platelet Biologic Reduces Hemorrhage After Traumatic Brain Injury
- Minimally Invasive Probe Measures Key Metabolic Markers Simultaneously
- AI Expands Across Heart Failure Care Continuum to Improve Management
- Wearable Cardiac Monitor with Cellular Transmission Enhances Remote Arrhythmia Detection
- Microneedle Sensor Enables Continuous Monitoring of Drug Clearance
- 3D Brain Imaging Marker Predicts Surgical Outcomes in Dementia-Causing Hydrocephalus
- Printed Artificial Neurons Stimulate Natural Brain Circuits
- Review Advances Precision Care Pathway for Meningioma Management
- Synthetic Biology Approach Enables On-Demand Liver Tissue Growth
- Bioinspired Imaging System Identifies Cancerous Lymph Nodes Intraoperatively
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read more
Surgical Techniques
view channel
Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes
Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Torqueable Microcatheters Enhance Navigation in Complex Coronary Lesions
Interventional cardiologists frequently encounter tortuous vessels and heavily calcified or fibrotic coronary lesions that complicate guidewire control and device delivery. Stable, predictable torque and... Read more
Transcatheter Venous Arterialization Improves Outcomes in No-Option Limb Ischemia Patients
Chronic limb-threatening ischemia (CLTI) is an advanced stage of peripheral artery disease in which plaque narrows leg arteries and severely restricts blood flow, leading to pain, nonhealing wounds, and... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Point of Care
view channel
Business
view channel
Johnson & Johnson Launches AI-Driven Cardiac Mapping System
Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more
